ArticleMSMR2025
Malaria among members of the U.S. Armed Forces, 2024.
Article in MSMR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malaria infection remains a potential health threat to U.S. service members located in or near endemic areas due to duty assignments, participation in contingency operations, or personal travel. In 2024, a total of 30 active and reserve component service members were diagnosed with or reported to have malaria, a 23.1% decrease from the 39 cases identified in 2023. Over half of U.S. service member malaria cases in 2024 were caused by Plasmodium falciparum (56.7%, n=17), followed by unspecified types of malaria (33.3%, n=10) and P. vivax (10.0%, n=3). Malaria cases were diagnosed or reported from 18 different medical facilities in the U.S., Germany, Africa, Japan, Middle East, and South Korea. Of the 27 cases with a known location of diagnosis, 11 (40.7%) were reported or diagnosed outside the U.S. This report documents a total of 30 malaria cases in 2024, a 23.1% decrease from 39 cases in 2023, mainly due to declines in Africa and other or unspecified locations. As in 2023, Plasmodium falciparum continues to constitute over half of new malaria cases (n=17, 56.7%) among active and reserve component U.S. service members.
Indexed as
Identifiers
40305837PMC12091955What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.